Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review-Reference-Cited by-同舟云学术

Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review

Published:2018-12 Issue:6 Volume:16 Page:e1087-e1090
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Di Stefano Rosario F.,Buttigliero Consuelo^ORCID,De Luca Emmanuele,Reale Maria Lucia,Pisano Chiara,Leone Gianmarco,Zichi Clizia,Massa Federica,Manfredi Matteo^ORCID,Vignani Francesca,Bollito Enrico,Porpiglia Francesco,Di Maio Massimo,Tucci Marcello

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference20 articles.

1. Renal medullary carcinoma. The seventh sickle cell nephropathy;Davis;Am J Surg Pathol,1995

2. Clinical outcome and prognostic factors in renal medullary carcinoma: a pooled analysis from 18 years of medical literature;Iacovelli;Can Urol Assoc J,2015

3. Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study;Shah;BJU Int,2017

4. Outcome of patients with renal medullary carcinoma (RMC) treated in the era of targeted therapies (TT): a multicenter experience;Tannir;J Clin Oncol,2011

5. Renal medullary carcinoma: establishing standards in practice;Beckermann;J Oncol Pract,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumeurs de Bellini et carcinomes médullaires rénaux à l’ère des nouvelles thérapies;Bulletin du Cancer;2023-04

2. Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back Again;American Society of Clinical Oncology Educational Book;2022-07

3. Renal Medullary Carcinoma: a Report of the Current Literature;Current Urology Reports;2019-01

4. Nivolumab;Reactions Weekly;2019-01